90 related articles for article (PubMed ID: 36136306)
1. Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer.
Sun L; Candelieri-Surette D; Anglin-Foote T; Lynch JA; Maxwell KN; D'Avella C; Singh A; Aakhus E; Cohen RB; Brody RM
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1022-1028. PubMed ID: 36136306
[TBL] [Abstract][Full Text] [Related]
2. Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer.
Han J; Zakeri K; Raab G; Hesse J; Shamseddine A; Chen L; Yu Y; Kang JJ; McBride SM; Riaz N; Tsai CJ; Gelblum D; Sherman EJ; Wong RJ; Michel L; Lee NY
Head Neck; 2023 Sep; 45(9):2207-2216. PubMed ID: 37439286
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC).
Shapiro LQ; Sherman EJ; Riaz N; Setton J; Koutcher L; Zhang Z; Shi W; Fury MG; Wolden SL; Pfister DG; Morris L; Lee N
Oral Oncol; 2014 Oct; 50(10):947-55. PubMed ID: 25132089
[TBL] [Abstract][Full Text] [Related]
4. A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.
Rühle A; Weymann M; Behrens M; Marschner S; Haderlein M; Fabian A; Senger C; Dickstein DR; Kraft J; von der Grün J; Chen E; Aquino-Michaels T; Domschikowski J; Bickel A; Altay-Langguth A; Kalinauskaite G; Lewitzki V; Bonomi M; Blakaj DM; Jhawar SR; Baliga S; Barve R; Ferentinos K; Zamboglou C; Schnellhardt S; Haehl E; Spohn SKB; Kuhnt T; Zöller D; Guckenberger M; Budach V; Belka C; Bakst R; Mayer A; Schmidberger H; Grosu AL; Balermpas P; Stromberger C; Nicolay NH
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1282-1293. PubMed ID: 37914144
[TBL] [Abstract][Full Text] [Related]
5. A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
Ngamphaiboon N; Pattaranutaporn P; Lukerak S; Siripoon T; Jinawath A; Arsa L; Shantavasinkul PC; Taonam N; Trachu N; Jinawath N; Kositwattanarerk A; Sananmuang T; Jiarpinitnun C
Clin Cancer Res; 2024 Jan; 30(2):294-303. PubMed ID: 37982827
[TBL] [Abstract][Full Text] [Related]
6. Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.
Korpics MC; Turchan WT; Koshy M; Spiotto MT
Head Neck; 2022 Jul; 44(7):1528-1544. PubMed ID: 35393753
[TBL] [Abstract][Full Text] [Related]
7. Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.
Bourhis J; Burtness B; Licitra LF; Nutting C; Schoenfeld JD; Omar M; Bouisset F; Nauwelaerts H; Urfer Y; Zanna C; Cohen EE
Future Oncol; 2022 May; 18(14):1669-1678. PubMed ID: 35172587
[TBL] [Abstract][Full Text] [Related]
8. Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study.
Wang HC; Liu PL; Lo PC; Chang YT; Chan LP; Yeh TJ; Hsiao HH; Cho SF
PeerJ; 2020; 8():e9862. PubMed ID: 32974098
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
Tanaka R; Ueki Y; Ohshima S; Omata J; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Ohtaki K; Togashi T; Horii A
Int J Clin Oncol; 2024 May; ():. PubMed ID: 38727853
[TBL] [Abstract][Full Text] [Related]
10. Treatment with (chemo)-radiation in old patients (≥76 years of age) with newly diagnosed non-metastatic squamous cell cancer of the head and neck region: real-world data from a tertiary referral center.
Winkler LS; Haderlein M; Semrau S; Putz F; Höfler D; Müller SK; Iro H; Kesting M; Fietkau R; Schubert P
Front Oncol; 2024; 14():1382405. PubMed ID: 38725619
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database.
Lu HJ; Hsieh MC; Wang HM; Hsieh JC; Yen CJ; Wu SY; Huang HC; Wang HC; Chu PY; Chen TH; Chien CY; Huang TL; Chang YF; Hua CH; Lien MY; Chen JP; Lu WC; Lin JC; Wang CC; Liu YC; Yang MH; Lou PJ
Head Neck; 2024 May; 46(5):1063-1073. PubMed ID: 38385970
[TBL] [Abstract][Full Text] [Related]
12. Comparing the Efficacy of Carboplatin plus 5-Fluorouracil, Cisplatin plus 5-Fluorouracil, and Best Supportive Care for Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Analysis from a Tertiary Hospital in Southern Thailand.
Wonglhow J; Wetwittayakhlang P; Sunpaweravong P; Sathitruangsak C; Dechaphunkul A
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541960
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancer.
Albarmawi H; Cullen KJ; Mehra R; Onukwugha E; Goloubeva O
J Comp Eff Res; 2022 Jun; 11(8):595-607. PubMed ID: 35543585
[No Abstract] [Full Text] [Related]
14. Association of Social-Ecological Factors With Delay in Time to Initiation of Postoperative Radiation Therapy: A Prospective Cohort Study.
Sawaf T; Virgen CG; Renslo B; Farrokhian N; Yu KM; Somani SN; Bur AM; Kakarala K; Shnayder Y; Gan GN; Graboyes EM; Sykes KJ
JAMA Otolaryngol Head Neck Surg; 2023 Jun; 149(6):477-484. PubMed ID: 37079327
[TBL] [Abstract][Full Text] [Related]
15. Causes and Ways of Death in Patients With Head and Neck Cancer.
van den Besselaar BN; Sewnaik A; Hoesseini A; Dorr MC; Baatenburg de Jong RJ; Offerman MPJ
JAMA Otolaryngol Head Neck Surg; 2024 Apr; 150(4):303-310. PubMed ID: 38358760
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab concomitant with second-line radiation therapy in patients with locally advanced recurrent squamous cell head and neck cancer.
Akmansu M; Buyukberber S; Iren S; Demirci U; Kanyilmaz G; Coskun U; Bora H
Case Rep Oncol; 2010 Sep; 3(3):480-8. PubMed ID: 21611102
[TBL] [Abstract][Full Text] [Related]
17. Stroke death in patients receiving radiation for head and neck cancer in the modern era.
Hardy SJ; Bandyopadhyay S; Yang H; Williams A; Gudina A; Cummings MA; Zhang H; Singh DP; Chen Y; Mohile NA; Janelsins MC; Milano MT
Front Oncol; 2023; 13():1111764. PubMed ID: 37397363
[TBL] [Abstract][Full Text] [Related]
18. Audiologic Evaluation of Patients with Head and Neck Cancers Treated with Cisplatin Based Chemotherapy: A Longitudinal Study.
Shofoluwe NA; Shuaibu IY; Mohammed IB; Chitumu D; Usman MA; Nwaorgu OGB; Salisu AD
Niger Med J; 2021; 62(2):85-91. PubMed ID: 38505572
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Effect of Metformin on the Five-Year Survival in about 40,000 Patients with Head and Neck Cancer.
Gaertner F; Preissner S; Heiland M; Preissner R; Wüster J
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473343
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
